Medical Advisor

Inno Care (HKEX: 09969; SSE: 688428) is a commercial stage biopharmaceutical company committed to discovering, developing, and commercializing innovative drugs for the treatment of cancers and autoimmune disease, with unmet medical needs worldwide. Inno Care has built up a fully integrated platform in terms of research and development, clinical development, manufacturing and commercialization. To date, the Company has developed a robust product pipeline comprising three approved drugs (orelabrutinib, tafasitamab and zurletrectinib), and more than ten innovative drug candidates in clinical development, and multiple programs in preclinical stages. Inno Care has successfully got listed on both Hong Kong Stock Exchange and the STAR Board of Shanghai Stoch Exchange. Our world-class team exhibits remarkable synergy and efficient execution, with entrepreneurial spirit, which has made outstanding achievements in innovation, commercialization and globalization. If you would like to join us, we will develop innovative drugs for the benefit of patients worldwide. Website link: https://www.innocarepharma.com/en. Linked In: Inno Care Pharma. Key Responsibilties Deep understand of relevant therapeutic areas; Collect and share insights with cross-functional team; Building Innocare’s reputation via implementation of high-quality medical programs; Lead formulation and execution of medical strategy from a cross-section of internal and external stakeholders to support key medical message communication and KOL engagement; Responsible for the review of promotional or educational materials; Provide expert review of training, promotional and project-based activity materials from a scientific viewpoint.